BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Akorn, Inc. 

1925 West Field Court

Lake Forest  Illinois  60045  U.S.A.
Phone: 847-279-6100 Fax: 847-236-3823


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Discovery





 Company News
Akorn, Inc. (AKN) Reports Preliminary 2014 Third Quarter Results 11/6/2014 10:57:47 AM
Akorn, Inc. (AKN) Announces Third Quarter 2014 Earnings Release And Conference Call Information 10/21/2014 10:43:37 AM
Akorn, Inc. (AKN) Ponies Up $45 Million Cash For Sunovion Pharmaceuticals Inc.'s Xopenex® (levalbuterol HCI) Inhalation Solution 10/1/2014 5:53:07 AM
Illinois-Based Akorn, Inc. (AKN) Eyes $2 Billion UCB SA Unit In Potential Tax Inversion Deal 9/12/2014 6:38:34 AM
Akorn, Inc. (AKN) Completes Acquisition Of VersaPharm 8/12/2014 7:51:00 AM
Akorn, Inc. (AKN) Reports Preliminary 2014 Second Quarter Results 8/5/2014 7:53:24 AM
Akorn, Inc. (AKN) Announces Second Quarter 2014 Earnings Release And Conference Call Information 7/15/2014 10:43:11 AM
Akorn, Inc. (AKN) Divests ECR Pharmaceuticals To Valeant Pharmaceuticals International (VRX) For $41 Million Cash 6/20/2014 11:03:16 AM
Akorn, Inc. (AKN) Picks Up VersaPharm For $440 Million 5/9/2014 7:23:09 AM
Akorn, Inc. (AKN) Reports 2014 First Quarter Results 5/6/2014 7:58:35 AM
12345678910...